References:
Tarantino G, Citro V, Finelli C. Hype or reality: Should patients with metabolic syndrome-related NAFLD be on the lookout for bergamot polyphenolic fraction (BPF)? Aliment Pharmacol Ther. 2011;34(3):274-285. doi:10.1111/j.1365-2036.2011.04716.x
Bergamet. Bergamet’s significant effect in fatty liver disease prompts call for US research proposals. Published 2023. Accessed August 6, 2025. https://bergamet.com.au/bergamets-significant-eff...
Journal of Alternative and Complementary Science. Volume 18. Issue July 11, 2012.
Mollace V, et al. Hypolipemic and hypoglycaemic activity of bergamot polyphenols: From animal models to human studies. PharmaNutrition. 2016;2(2):61–67. doi:10.1016/j.phanu.2016.05.001
PharmaNutrition. Elsevier. Published online March 11, 2016. doi:10.1016/j.phanu.2016.05.001